Estimating treatment effects from a randomized controlled trial with mid-trial design changes.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 209, doi. 10.1177/17407745241304120
- By:
- Publication type:
- Article
Works matching IS 17407745 AND DT 2025 AND VI 22 AND IP 2
Results: 14
1
2
Consent to recontact for future research using linked primary healthcare data: Outcomes and general practice perceptions from the ATHENA COVID-19 study.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 188, doi. 10.1177/17407745241304094
- By:
- Publication type:
- Article
3
Investigating the presence of surgical learning in the Timing of Primary Surgery for cleft palate randomised trial.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 200, doi. 10.1177/17407745241302488
- By:
- Publication type:
- Article
4
NHS-Galleri trial: Enriched enrolment approaches and sociodemographic characteristics of enrolled participants.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 227, doi. 10.1177/17407745241302477
- By:
- Publication type:
- Article
5
Commentary on Toerper et al: A step in the right direction for learning health systems.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 152, doi. 10.1177/17407745241302023
- By:
- Publication type:
- Article
6
Use of Epic ® to facilitate high-quality randomization of emergency department-based pragmatic clinical trials.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 142, doi. 10.1177/17407745241301998
- By:
- Publication type:
- Article
7
Detecting irregularities in randomized controlled trials using machine learning.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 178, doi. 10.1177/17407745241297947
- By:
- Publication type:
- Article
8
Assessing institutional responsibility in scientific misconduct: A case study of enoximone research by Joachim Boldt.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 239, doi. 10.1177/17407745241297162
- By:
- Publication type:
- Article
9
UK paediatric clinical trial protocols: A review of guidance for participant management and care in the event of premature termination.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 220, doi. 10.1177/17407745241296864
- By:
- Publication type:
- Article
10
Pragmatic monitoring of emerging efficacy data in randomized controlled trials.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 155, doi. 10.1177/17407745241290729
- By:
- Publication type:
- Article
11
The state of individual participant data sharing for the highest-revenue medicines.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 170, doi. 10.1177/17407745241286147
- By:
- Publication type:
- Article
12
Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE ®) in a diverse cancer sample.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 161, doi. 10.1177/17407745241286065
- By:
- Publication type:
- Article
13
Using non-inferiority test of proportions in design of randomized non-inferiority trials with time-to-event endpoint with a focus on low-event-rate setting.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 131, doi. 10.1177/17407745241284786
- By:
- Publication type:
- Article
14
Ethical considerations for sharing aggregate results from pragmatic clinical trials.
- Published in:
- Clinical Trials, 2025, v. 22, n. 2, p. 248, doi. 10.1177/17407745241290782
- By:
- Publication type:
- Article